CTX112
CRSP-AID-501
Phase 2 mab active
Quick answer
CTX112 for Warm Autoimmune Hemolytic Anemia (WAIHA) is a Phase 2 program (mab) at CRISPR Therapeutics AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CRISPR Therapeutics AG
- Indication
- Warm Autoimmune Hemolytic Anemia (WAIHA)
- Phase
- Phase 2
- Modality
- mab
- Status
- active